- Attention deficit hyperacidity disorder (ADHD):
- PO 18-36mg OD OR 20-30mg/day divided BD/TDS
- May increase by 18-mg increments at weekly intervals
- Maintenance: 18-72mg/day
- Narcolepsy:
- PO 20-30mg/day divided BD/TDS
- Tablet:
- 10mg
- 18mg
- 27mg
- 36mg
- 54mg
- Taken 30-45 minutes before meals
Norepinephrine-Dopamine Reuptake Inhibitors (NDRIs)
It stimulates CNS activity, blocks reuptake and increases release of norepinephrine and dopamine in extraneuronal space
- Nervousness
- Insomnia
- Anorexia
- Abdominal pain
- Tachycardia
- Nausea
- Headache
- Palpitations
- Dizziness
- Xerostomia
- Irritability
- Hyperhidrosis
- Changes in BP
- Changes in HR
- Visual disturbance
- Weight loss (long-term use)
- Hypersensitivity to components/class
- MAO inhibitor use within 14 days
- Severe agitation
- Severe anxiety
- Motor tics
- Tourette syndrome or family history
- Severe cardiovascular disease
- Cardiac structural abnormality
- Severe arrhythmia
- Cardiomyopathy
- CAD
- Glaucoma
WARNING:
- Risk of abuse and dependence
- Benzphetamine
- Diethylpropion
- Isocarboxazid
- Linezolid
- Phendimetrazine
- Phenelzine
- Phentermine
- Rasagiline
- Safinamide
- Selegiline
- Tranylcypromine
Drug Status
| Availability | Prescription only |
| Pregnancy | Category D |
| Breastfeeding | Weigh risk vs benefit |
| Schedule | Controlled |
| BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
|---|---|---|---|---|---|
| Concerta | 18mg | Tablet | 30’s | Janssen Pharmaceutica | Janssen Pharmaceutica |
| Concerta | 36mg | Tablet | 30’s | Janssen Pharmaceutica | Janssen Pharmaceutica |
| Concerta | 27mg | Tablet | 30’s | Janssen Pharmaceutica | Janssen Pharmaceutica |
| Concerta | 54mg | Tablet | 30’s | Janssen Pharmaceutica | Janssen Pharmaceutica |
| Ritalin | 10mg | Tablet | 30’s | Novartis Pharma | Novartis Kenya |